Andrea Ippolito, CEO, Simplifed

Andrea Ippolito has combined her personal experience as a mum struggling with breast feeding, and her professional career as an entrepreneur and engineer at Athenahealth building integrations with EMRs. She’s now the CEO of Simplifed which has built a network of lactation consultants, and much more, and has placed it in the workflow of that…

Read More

Man and Machine: A New Age for Medicine

By MIKE MAGEE “As machines become more intelligent and can performance more sophisticated functions, a new relationship between human and automation is dawning. This relationship is moving from master-servant to teammates…” NASA Langley Research Center/2019 “DeepSeek’s Breakthrough Sparks National Pride in China,” screamed the Wall Street Journal headline last week. In the age of Trump’s…

Read More

Journalists Untangle Issues of Health Care Costs and Food Benefits

KFF Health News Southern California correspondent Claudia Boyd-Barrett discussed rising health care premiums on KPFA’s “Up Front” on Nov. 13. Click here to hear Boyd-Barrett on “Up Front” (starts at 08:19). Read Boyd-Barrett’s “Health Care Costs Jump to the Fore as Candidates Jockey To Be California Governor.” KFF Health News chief Washington correspondent Julie Rovner…

Read More

Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash

Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Work Requirements Unfairly Burden Medicaid Applicants Great story (“A Deloitte-Run System Denied Medicaid Benefits for Michigan’s Disabled. Now Trump’s Law Piles On,” July 21). However, a key point was missed. The…

Read More

FDA Voucher Leads to Speedy Approval of Boehringer Drug for First-Line Use in Lung Cancer

The label expansion for Boehringer Ingelheim’s Hernexeos was made under an FDA pilot program that accelerates regulatory review of products with national interest. The daily pill is now approved as a first-line treatment for HER2-positive non-small lung cancer, an indication with few treatment options. The post FDA Voucher Leads to Speedy Approval of Boehringer Drug…

Read More